Meningitis

Vaccine Efficacious in First Large-Scale Demonstration

Published in TB and Outbreaks Week, March 2nd, 1998

A vaccine for meningitis is useful in controlling the most common type of meningitis outbreak in the United States, according to an article in the February 11, 1998, issue of The Journal of the American Medical Association (JAMA, 1998;280:435-439).

Nancy Rosenstein, MD, of the National Center for Infectious Diseases at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, and colleagues conducted the first study of the vaccine's efficacy when used in a mass vaccination campaign of U.S. civilians aged two- to 29-years-old.

They found the vaccine was 85 percent effective among the entire group and 93 percent effective among those...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1998-03-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry